FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...
Reminder test emails for the Health and Human Services (HHS) email notifications for WNV reactives h...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...
Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the begi...
As winter weather continues to move through parts of the US, we would like to remind you it may be n...